The global intranasal drug and vaccine delivery market is expected to increase by USD 30.9 十亿, 以复合年增长率 (复合年增长率) 的 6.7% 从 2022 到 2028, according to the latest edition of the Global Intranasal Drug and Vaccine Delivery Market Report.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global intranasal drug and vaccine delivery market. 它追踪市场的历史和预测市场增长. 该报告根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the intranasal drug and vaccine delivery industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, dosage, 应用, 分销渠道, 和地区. The global market for intranasal drug and vaccine delivery can be segmented by product: powder delivery device, liquid delivery device, pressurized metered dose inhalers, 其他的. 据研究, the liquid delivery device segment had the largest share in the global intranasal drug and vaccine delivery market. Intranasal drug and vaccine delivery market is further segmented by dosage: unit-dose, multi-dose. 在 2021, the multi-dose segment made up the largest share of revenue generated by the intranasal drug and vaccine delivery market. 根据应用, the intranasal drug and vaccine delivery market is segmented into: respiratory disorders, neurological disorders, vaccination, pain management, 其他的. 在这些当中, the respiratory disorders segment was accounted for the highest revenue generator in 2021. 以分销渠道为基础, the intranasal drug and vaccine delivery market also can be divided into: 医院, 零售, 在线的, 其他的. 零售业占据了最大的市场份额 2021. Intranasal drug and vaccine delivery market by region is categorized into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美.

市场细分
副产品: powder delivery device, liquid delivery device, pressurized metered dose inhalers, 其他的
By dosage: unit-dose, multi-dose
按申请: respiratory disorders, neurological disorders, vaccination, pain management, 其他的
按分销渠道: 医院, 零售, 在线的, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report also provides analysis of the key companies of the industry and their detailed company profiles including Aptar Group, 公司, Bespak Europe Ltd., 葛兰素史克公司, Glenmark Pharmaceuticals Ltd., 梯瓦制药工业有限公司, UCB, 公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global intranasal drug and vaccine delivery market.
– To classify and forecast the global intranasal drug and vaccine delivery market based on product, dosage, 应用, 分销渠道, 地区.
– To identify drivers and challenges for the global intranasal drug and vaccine delivery market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global intranasal drug and vaccine delivery market.
– To identify and analyze the profile of leading players operating in the global intranasal drug and vaccine delivery market.

为什么选择这份报告
– Gain a reliable outlook of the global intranasal drug and vaccine delivery market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.